Evidence map›Paper›PMID 40020072›Full record

ArticleScience advances2025

Cystic fibrosis alters the structure of the olfactory epithelium and the expression of olfactory receptors affecting odor perception.

Ignacio Caballero, Yvon Mbouamboua, Susanne Weise, Raquel López-Gálvez, Marie Couralet, Isabelle Fleurot, Nicolas Pons, Marta Barrera-Conde, Nayima Quílez-Playán, Matthieu Keller and 5 more

Erratum issuedAbstract read
In one paragraph

Article in Science advances, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Olfactory models as a platform for neuroscience research.Frontiers in cellular neuroscience · 2026
    Review
  5. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

15 authors.

Ignacio CaballeroInfectiologie et Santé Publique, UMR1282, INRAE, University of Tours, 37380 Nouzilly, France.ORCID 0000-0002-0628-4134
Yvon MbouambouaUniversité Côte d'Azur, CNRS, INSERM, Institut de Pharmacologie Moléculaire et Cellulaire, 06560 Sophia Antipolis, France.ORCID 0000-0002-7764-829X
Susanne WeiseDepartment of Otorhinolaryngology, Smell & Taste Clinic, Carl Gustav Carus University Hospital, Technische Universität Dresden, 01307 Dresden, Germany.
Raquel López-GálvezInfectiologie et Santé Publique, UMR1282, INRAE, University of Tours, 37380 Nouzilly, France.ORCID 0000-0002-8458-4351
Marie CouraletUniversité Côte d'Azur, CNRS, INSERM, Institut de Pharmacologie Moléculaire et Cellulaire, 06560 Sophia Antipolis, France.ORCID 0000-0002-4581-8418
Isabelle FleurotInfectiologie et Santé Publique, UMR1282, INRAE, University of Tours, 37380 Nouzilly, France.ORCID 0000-0002-0728-251X
Nicolas PonsUniversité Côte d'Azur, CNRS, INSERM, Institut de Pharmacologie Moléculaire et Cellulaire, 06560 Sophia Antipolis, France.
Marta Barrera-CondeIntegrative Pharmacology and Systems Neuroscience, Neuroscience Research Program, IMIM-Hospital del Mar Research Institute, 08003 Barcelona, Spain.
Nayima Quílez-PlayánLaboratoire de Physiologie de la Reproduction et des Comportements, CNRS, INRAE, University of Tours, 37380 Nouzilly, France.ORCID 0000-0001-6593-8057
Matthieu KellerLaboratoire de Physiologie de la Reproduction et des Comportements, CNRS, INRAE, University of Tours, 37380 Nouzilly, France.ORCID 0000-0002-5445-7431
Nikolai KlymiukFirst Department of Medicine, Cardiology, Klinikum rechts der Isar, Technical University of Munich, School of Medicine and Health, Munich, Germany.ORCID 0000-0003-3532-1659
Patricia RobledoIntegrative Pharmacology and Systems Neuroscience, Neuroscience Research Program, IMIM-Hospital del Mar Research Institute, 08003 Barcelona, Spain.ORCID 0000-0002-7941-0939
Thomas HummelDepartment of Otorhinolaryngology, Smell & Taste Clinic, Carl Gustav Carus University Hospital, Technische Universität Dresden, 01307 Dresden, Germany.ORCID 0000-0001-9713-0183
Pascal BarbryUniversité Côte d'Azur, CNRS, INSERM, Institut de Pharmacologie Moléculaire et Cellulaire, 06560 Sophia Antipolis, France.ORCID 0000-0001-9632-6483
Pablo ChameroLaboratoire de Physiologie de la Reproduction et des Comportements, CNRS, INRAE, University of Tours, 37380 Nouzilly, France.ORCID 0000-0002-4305-1073

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

A reduced sense of smell is a common condition in people with cystic fibrosis (CF) that negatively affects their quality of life. While often attributed to nasal mucosa inflammation, the underlying causes of the olfactory loss remain unknown. Here, we characterized gene expression in olfactory epithelium cells from patients with CF using single-nuclei RNA sequencing and found altered expression of olfactory receptors (ORs) and genes related to progenitor cell proliferation. We confirmed these findings in newborn, inflammation-free samples of a CF animal model and further identified ultrastructural alterations in the olfactory epithelium and bulbs of these animals. We established that CFTR, the anion channel whose dysfunction causes CF, is dispensable for odor-evoked signaling in sensory neurons, yet CF animals displayed defective odor-guided behaviors consistent with the morphological and molecular alterations. Our study highlights CF's major role in modulating epithelial structure and OR expression, shedding light on the mechanisms contributing to olfactory loss in CF.

Indexed as

Cystic FibrosisOlfactory MucosaOlfactory PerceptionReceptors, OdorantAnimalsCystic Fibrosis Transmembrane Conductance RegulatorDisease Models, AnimalFemaleGene Expression RegulationHumansMaleMiceOdorantsOlfactory Receptor NeuronsSmellCystic Fibrosis Transmembrane Conductance RegulatorReceptors, Odorant

Identifiers

PMID40020072
PMCPMC11870070

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.